The other amplified locus at 8q24.21 comprised the representative oncogene of MYC. Several experimental studies have shown that MYC amplification or overexpression is observed in early GC patients when tumor invasion is confined to the mucosa or submucosa, regardless of the presence of lymph node metastasis (2,18–22). This evidence concerns the gene MYC and neoplasm.